ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,742, issued on June 17, was assigned to ORION Corp. (Espoo, Finland).
"Pharmaceutical composition of darolutamide" was invented by Susanna Ilmonen (Espoo, Finland), Juha Lintunen (Espoo, Finland), Petteri Lyytinen (Espoo, Finland) and Marko Saalasti (Espoo, Finland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical composition for oral administration, particularly in the form of a tablet, comprising darolutamide or a pharmaceutically acceptable salt thereof as an active ingredient. Darolutamide is a potent androgen receptor (AR) modulator useful in the treatment of cancer, particularly AR dependent cance...